Breast cancer exhibits molecular heterogeneity (Barzaman et al., 2020; Yeo and Guan, 2017; Liu et al., 2022), encompassing distinct subtypes such as Luminal A, Luminal B, HER2-enriched, and Basal-like. This evidence concerns the gene ERBB2 and breast carcinoma.